The inhibitors of GLS in cancer Therapy worked by interfering with the metabolism of alpha-ketoglutarate, an intermediate of the tricarboxylic acid (TCA) cycle, some of which are undergoing clinical trials and exhibiting promising effects (39, 40). The gene discussed is GLS; the disease is cancer.